Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

This publication has 28 references indexed in Scilit:

• Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial
  Journal of Clinical Oncology, 1999
• Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines
  Biochemical Pharmacology, 1999
• Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
  International Journal of Cancer, 1999
• Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines.
  International Journal of Oncology, 1998
• New Chemotherapeutic Agents in the Treatment of Non-small Cell Lung Cancer
  Chest, 1998
• Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells
  Breast Cancer Research and Treatment, 1997
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Taxol in combination with doxorubicin or etoposide possible antagonism in vitro
  Cancer, 1993
• In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines
  Breast Cancer Research and Treatment, 1992
• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
  JNCI Journal of the National Cancer Institute, 1990